- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-75-0023119

Echinacea Meds India Private Limited
About Echinacea Meds India Private Limited
Data last updated:
Echinacea Meds India Private Limited is a private limited company based in Gurugram, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24122HR2019PTC079805. Its GSTIN is 09AAFCE4566P1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Ashish Gupta and Dhruv Chaturvedi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at J – 1/06 DLF Ph – II, Gurugram, Haryana, India – 122022.
As per the financials filed for FY 2025, the company reported a revenue of ₹63.42 Lakh, a decline of 77% compared to the previous year. For the same year it recorded a net profit of ₹58,598 (net margin 0.9%) and EBITDA of ₹11 Lakh (EBITDA margin 17.3%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Echinacea Meds India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-75-0023119).
Company details
Recognitions & Rankings of Echinacea Meds India
Contact details
Echinacea Meds India Private Limited's registered office is in Gurugram, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressJ – 1/06 DLF Ph – II, Gurugram, Haryana, India – 122022
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Echinacea Meds India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Echinacea Meds India is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Echinacea Meds India Private Limited, buy the company report.
Financials of Echinacea Meds India Private Limited
FY 2025 filings availableEchinacea Meds India Private Limited reported revenue of ₹63.42 Lakh (down 77% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 37% over three years, including a 77% fall in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹58,598 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.3% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Echinacea Meds India Private Limited, buy the company report.
Board of directors of Echinacea Meds India Private Limited
Echinacea Meds India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Gupta | Director | 18 Apr 2019 | 7 Years 6 Months | Current |
| Dhruv Chaturvedi Also directs: Lasenda Estate Private Limited | Director | 29 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Echinacea Meds India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Restone Industries Private Limited | ₹63.43 Lakh (FY 2025) | -30.0% | Dhanbad, Jharkhand, India | |||
| Nakshya Consultants Private Limited | ₹63.43 Lakh (FY 2016) | 39.0% | Kolkata, West Bengal, India | |||
| Rakesh Furniture & Glass House Private Limited | ₹63.42 Lakh (FY 2024) | Atarra, Uttar Pradesh, India | ||||
| Futurefab Global Sampling Place Private Limited | ₹63.42 Lakh (FY 2024) | 14913.0% | Gurgaon, Haryana, India | |||
| Adi Fashion House Private Limited | ₹63.42 Lakh (FY 2025) | -14.0% | Lucknow, Uttar Pradesh, India | |||
| Echinacea Meds India Private Limitedthis company | ₹63.42 Lakh (FY 2025) | ₹58,598 | 0.9% | -77.0% | Gurugram, Haryana, India | |
| Pradanta Technology Private Limited | ₹63.41 Lakh (FY 2023) | -28.0% | Gurugram, Haryana, India | |||
| Arya Retail Private Limited | ₹63.39 Lakh (FY 2023) | 251.0% | New Delhi, Delhi, India | |||
| Car Cop Private Limited | ₹63.39 Lakh (FY 2024) | 0.0% | Delhi, India | |||
| Ryllz Essentials Private Limited | ₹63.39 Lakh (FY 2025) | 169.0% | Ghaziabad, Uttar Pradesh, India | |||
| JS Fruits Private Limited | ₹63.38 Lakh (FY 2024) | -63.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Echinacea Meds India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 May 2022 | 100574584 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Echinacea Meds India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Echinacea Meds India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Echinacea Meds India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCE4566P1ZX | Uttar Pradesh | Active | 02 May 2019 |
To see the full GST registrations and return filing status of Echinacea Meds India Private Limited, buy the company report.
Recent activity
Echinacea Meds India Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Mohan Chaturvedi ceased to be Director on 30 Oct 2021.
Frequently asked questions
Echinacea Meds India is an active private limited company based in Gurugram, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 April 2019 (7+ years old) and is registered under CIN U24122HR2019PTC079805.
Echinacea Meds India has 2 current directors:
- Ashish Gupta - Director
- Dhruv Chaturvedi - Director
The latest financial statements of Echinacea Meds India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Echinacea Meds India is 09AAFCE4566P1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Echinacea Meds India is U24122HR2019PTC079805. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Echinacea Meds India was incorporated on 18 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Echinacea Meds India by revenue are Restone Industries Private Limited, Nakshya Consultants Private Limited, Rakesh Furniture & Glass House Private Limited, Futurefab Global Sampling Place Private Limited, Adi Fashion House Private Limited and 5 more, all in the same principal business activity (retail trading).
Mohan Chaturvedi ceased to be Director on 30 Oct 2021. Dhruv Chaturvedi was appointed as Director on 29 Oct 2021. Ashish Gupta was appointed as Director on 18 Apr 2019.
Yes, Echinacea Meds India is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-75-0023119).
The registered office of Echinacea Meds India is at J – 106 DLF Ph – II, Gurugram, Haryana, India – 122022.
Echinacea Meds India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

